P1401: IDENTIFICATION OF BIOMARKERS AND RISK FACTORS FOR IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME (ICANS) IN CD19-DIRECTED CAR T-CELL THERAPY: A RETROSPECTIVE MACHINE LEARNING-BASED ANALYSIS.

• Marina Gómez-Llobell,
• María Martínez García,
• Carlos Serra Smith,
• Daniel Gómez Costas,
• Gillen Oarbeascoa Royuela,
• Diego Carbonell,
• Javier Anguita Velasco,
• Ana María Pérez Corral,
• Marjorie Pion,
• Veronica Astrid Pérez-Fernández,
• Isabel Fernández García,
• Mariana Bastos Oreiro,
• Paula Fernández-Caldas González,
• Ignacio Gómez-Centurión,
• Ana Alarcón,
• Eva Catalá,
• Diego Conde,
• Jorge Gayoso,
• Pablo Olmos,
• Carolina Martínez Laperche,
• Jose García-Domínguez,
• Yolanda Fernández,
• Rebeca Bailen,
• MI Kwon

Affiliations

Marina Gómez-Llobell

1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain

María Martínez García

2 Gregorio Marañón Health Research Institute, Madrid, Spain

Carlos Serra Smith

4 Gregorio Marañón General University Hospital, Neurology Department, Madrid, Spain

Daniel Gómez Costas

5 Gregorio Marañón General University Hospital, Pharmacy Department, Madrid, Spain

Gillen Oarbeascoa Royuela

1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain

Diego Carbonell

1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain

Javier Anguita Velasco

1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain

Ana María Pérez Corral

1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain

Marjorie Pion

7 Gregorio Marañon Hospital, Immunology Department, madrid, Spain

Veronica Astrid Pérez-Fernández

7 Gregorio Marañon Hospital, Immunology Department, madrid, Spain

Isabel Fernández García

8 Gregorio Marañón Hospital, Nuclear Medicine Department, madrid, Spain

Mariana Bastos Oreiro

1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain

Paula Fernández-Caldas González

1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain

Ignacio Gómez-Centurión

1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain

Ana Alarcón

1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain

Eva Catalá

1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain

Diego Conde

1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain

Jorge Gayoso

1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain

Pablo Olmos

2 Gregorio Marañón Health Research Institute, Madrid, Spain

Carolina Martínez Laperche

1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain

Jose García-Domínguez

4 Gregorio Marañón General University Hospital, Neurology Department, Madrid, Spain

Yolanda Fernández

4 Gregorio Marañón General University Hospital, Neurology Department, Madrid, Spain

Rebeca Bailen

1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain

MI Kwon

1 Gregorio Marañón General University Hospital, Department of Hematology, Madrid, Spain